🇺🇸 FDA
Pipeline program

Vicadrostat

1378-0023

Phase 2 small_molecule active

Quick answer

Vicadrostat for Chronic Kidney Disease is a Phase 2 program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim
Indication
Chronic Kidney Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials